Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial-Reference-Cited by-同舟云学术

Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial

Published:2022-02-28 Issue:1 Volume:20 Page:143-153
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Shim Se-hoon¹^ORCID,Woo Young Sup²^ORCID,Kim Ji Sun¹^ORCID,Heo In Soo¹^ORCID,Yoon Hee-jung³^ORCID,Sung Hyung Mo⁴^ORCID,Lee Jonghun⁵^ORCID,Bahk Won-Myong²^ORCID

Affiliation:

1. Department of Psychiatry, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea

2. Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea

3. Korean Society of Infectious Diseases, Seoul, Korea

4. Department of Psychiatry, Soonchunhyang University Gumi Hospital, Soonchunhyang University College of Medicine, Gumi, Korea

5. Department of Psychiatry, Daegu Catholic University School of Medicine, Daegu, Korea

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

http://pdf.medrang.co.kr/CPN2/2022/020/cpn020-01-14.pdf

Reference39 articles.

1. Functional disability and depression in the general population. Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS)

2. MEASURING COGNITIVE FUNCTION IN MDD: EMERGING ASSESSMENT TOOLS

3. Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder

4. Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future

5. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder;Expert Review of Neurotherapeutics;2024-06-25

2. Prevalence and Comorbidities of Adult Attention-deficit/hyperactivity Disorder in a Community Sample from Korea;Clinical Psychopharmacology and Neuroscience;2023-11-30

3. Efficacy and Safety of Methylphenidate and Atomoxetine in Medication-Naive Children with Attention-Deficit Hyperactivity Disorder in a Real-World Setting;Drugs in R&D;2023-11-20

4. Beyond Attention-Deficit Hyperactivity Disorder: Exploring Psychiatric Comorbidities and Their Neuropsychological Consequences in Adults;Journal of the Korean Academy of Child and Adolescent Psychiatry;2023-10-01

5. Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis;CNS Drugs;2023-05